CW Advisors LLC lifted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 3.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,263 shares of the semiconductor company's stock after purchasing an additional 1,102 shares during the quarter. CW Advisors LLC's holdings in Synopsys were worth $16,410,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in the business. Cornerstone Planning Group LLC grew its stake in shares of Synopsys by 275.0% during the 1st quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after buying an additional 44 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Synopsys by 441.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock valued at $28,000 after purchasing an additional 53 shares during the period. Ameriflex Group Inc. purchased a new stake in shares of Synopsys during the fourth quarter valued at approximately $29,000. Cloud Capital Management LLC purchased a new stake in shares of Synopsys during the first quarter valued at approximately $36,000. Finally, Meeder Asset Management Inc. raised its position in shares of Synopsys by 33.3% in the 1st quarter. Meeder Asset Management Inc. now owns 104 shares of the semiconductor company's stock valued at $45,000 after purchasing an additional 26 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.
Insider Activity
In other news, CFO Shelagh Glaser sold 7,310 shares of Synopsys stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the sale, the chief financial officer owned 15,291 shares of the company's stock, valued at approximately $7,427,144.52. This trade represents a 32.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CRO Richard S. Mahoney sold 9,010 shares of the company's stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the completion of the sale, the executive owned 1,485 shares in the company, valued at approximately $699,746.85. This represents a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 27,686 shares of company stock valued at $13,001,048. 0.62% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on the company. The Goldman Sachs Group initiated coverage on Synopsys in a research report on Thursday, July 10th. They issued a "buy" rating and a $620.00 target price on the stock. Piper Sandler lifted their target price on Synopsys from $615.00 to $660.00 and gave the company an "overweight" rating in a research note on Monday, July 21st. Bank of America upped their target price on shares of Synopsys from $575.00 to $625.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Needham & Company LLC reissued a "buy" rating and set a $660.00 target price (up previously from $650.00) on shares of Synopsys in a research note on Tuesday, July 15th. Finally, KeyCorp boosted their price target on shares of Synopsys from $540.00 to $610.00 and gave the stock an "overweight" rating in a research report on Thursday, July 10th. Twelve equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Synopsys presently has an average rating of "Moderate Buy" and an average price target of $626.79.
Get Our Latest Research Report on SNPS
Synopsys Stock Up 1.4%
Shares of Synopsys stock traded up $8.35 during midday trading on Friday, reaching $606.52. 863,153 shares of the company's stock traded hands, compared to its average volume of 1,265,589. The company has a market cap of $94.11 billion, a price-to-earnings ratio of 43.79, a price-to-earnings-growth ratio of 3.99 and a beta of 1.15. The company's 50 day simple moving average is $570.29 and its 200 day simple moving average is $500.54. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, topping analysts' consensus estimates of $3.40 by $0.27. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The business had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.60 billion. During the same period in the previous year, the company earned $3.00 earnings per share. Synopsys's revenue for the quarter was up 10.3% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. Equities analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.